SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-21-019696
Filing Date
2021-08-12
Accepted
2021-08-12 16:10:52
Documents
86
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q nby20210630_10q.htm   iXBRL 10-Q 1352443
2 EXHIBIT 31.1 ex_272936.htm EX-31.1 9960
3 EXHIBIT 31.2 ex_272937.htm EX-31.2 9963
4 EXHIBIT 32.1 ex_272938.htm EX-32.1 4889
5 EXHIBIT 32.2 ex_272939.htm EX-32.2 5261
  Complete submission text file 0001437749-21-019696.txt   7817657

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA nby-20210630.xsd EX-101.SCH 90480
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE nby-20210630_cal.xml EX-101.CAL 49157
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE nby-20210630_def.xml EX-101.DEF 536552
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE nby-20210630_lab.xml EX-101.LAB 449234
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nby-20210630_pre.xml EX-101.PRE 569785
11 EXTRACTED XBRL INSTANCE DOCUMENT nby20210630_10q_htm.xml XML 1328845
Mailing Address 2000 POWELL STREET, SUITE 1150 EMERYVILLE CA 94608
Business Address 2000 POWELL STREET, SUITE 1150 EMERYVILLE CA 94608 (510) 899-8800
NovaBay Pharmaceuticals, Inc. (Filer) CIK: 0001389545 (see all company filings)

IRS No.: 680454536 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33678 | Film No.: 211167638
SIC: 2834 Pharmaceutical Preparations